» Articles » PMID: 22110329

Psychological Interventions in the Management of Common Skin Conditions

Overview
Publisher Dove Medical Press
Specialty Social Sciences
Date 2011 Nov 24
PMID 22110329
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The nervous system and the skin develop next to each other in the embryo and remain intimately interconnected and interactive throughout life. The nervous system can influence skin conditions through psychoneuroimmunoendocrine mechanisms and through behaviors. Understanding the pathophysiology aids in selection of treatment plans for correcting the negative effects of the psyche on specific skin conditions. Medication options include standard psychotropic medications and alternative herbs and supplements. Other options include biofeedback, cognitive-behavioral methods, hypnosis, meditation, progressive relaxation, the placebo effect, and suggestion. When simple measures fail, combining medications with other therapeutic options may produce better results. Skin conditions that have strong psychophysiologic aspects may respond well to techniques such as biofeedback, cognitive-behavioral methods, hypnosis, meditation, or progressive relaxation that help to counteract stress. Treatment of primary psychiatric disorders that negatively influence skin conditions often results in improvement of those skin conditions. Abnormal conditions of the skin, hair, and nails can also influence the psyche negatively. Treatment of secondary psychiatric disorders such as anxiety or depression that are triggered or exacerbated by the appearance of these skin conditions or the associated discomfort may also be required.

Citing Articles

Managing a Burning Face: Clinical Manifestations and Therapeutic Approaches for Neurogenic Rosacea.

Aedo G, Chahuan M, Gatica E, Herrera I, Parada L, Seguel A Int J Mol Sci. 2025; 26(5).

PMID: 40076987 PMC: 11901027. DOI: 10.3390/ijms26052366.


The Multiscale Wisdom of the Body: Collective Intelligence as a Tractable Interface for Next-Generation Biomedicine.

Levin M Bioessays. 2024; 47(3):e202400196.

PMID: 39623868 PMC: 11848127. DOI: 10.1002/bies.202400196.


Integrative Treatment Approaches with Mind-Body Therapies in the Management of Atopic Dermatitis.

Yosipovitch G, Canchy L, Roque Ferreira B, Aguirre C, Tempark T, Takaoka R J Clin Med. 2024; 13(18).

PMID: 39336855 PMC: 11432615. DOI: 10.3390/jcm13185368.


Psychodermatology of Chronic Pruritus: An Overview of the Link Between Itch and Distress.

Ferreira B, Katamanin O, Jafferany M, Misery L Dermatol Ther (Heidelb). 2024; 14(7):1799-1809.

PMID: 38914907 PMC: 11265050. DOI: 10.1007/s13555-024-01214-z.


A catena between psychiatric disorders and non-scarring alopecias-A systematic review.

Forneris Crego A, Therianou A, Hashemi P, Higgins C Skin Health Dis. 2023; 3(3):e194.

PMID: 37275427 PMC: 10233074. DOI: 10.1002/ski2.194.


References
1.
Fortune D, Richards H, Kirby B, Bowcock S, Main C, Griffiths C . A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. Br J Dermatol. 2002; 146(3):458-65. DOI: 10.1046/j.1365-2133.2002.04622.x. View

2.
Sampogna F, Picardi A, Chren M, Melchi C, Pasquini P, Masini C . Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004; 66(4):620-4. DOI: 10.1097/01.psy.0000132869.96872.b2. View

3.
Kroenke K, Sharpe M, Sykes R . Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics. 2007; 48(4):277-85. DOI: 10.1176/appi.psy.48.4.277. View

4.
Willemsen R, Roseeuw D, Vanderlinden J . Alexithymia and dermatology: the state of the art. Int J Dermatol. 2008; 47(9):903-10. DOI: 10.1111/j.1365-4632.2008.03726.x. View

5.
Masmoudi J, Maalej I, Masmoudi A, Rached H, Rebai A, Turki H . [Alexithymia and psoriasis: a case-control study of 53 patients]. Encephale. 2009; 35(1):10-7. DOI: 10.1016/j.encep.2007.11.009. View